AD 3
Add 1
Ad 2

Moderna stock falls by as much as 9.4% after report says late-stage coronavirus vaccine trial delayed

The company is making changes to its trial plan, which has pushed back the expected start date, according to health-care publication STAT News.

Leave A Reply